Due to the remarkable cancer-specific expression profile of ct-OATP1B3 [27, 29], it may represent a promising molecular target for cancer therapy using the herpes simplex virus 1 thymidine kinase-ganciclovir suicide gene system [43]. This evidence concerns the gene SLCO1B3 and cancer.